[Not Available]
Related Experiment Video
Updated: Mar 18, 2026
High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
Published on: November 15, 2013
Ghizlane Berrada El Azizi1, Samir Ahid1, Imane Ghannam1
1Équipe de Recherche de la Pharmacoépidémiologie et Pharmacoéconomie, Laboratoire de Pharmacologie et de Toxicologie, Faculté de Médecine et de Pharmacie, Université Mohammed V-Souissi, Rabat, Maroc.
Background:
To evaluate the evolution of consumption of antihypertensive drugs generic among 1991-2010, to assess the impacts after the institution of Mandatory Health Insurance and the marketing of generic drugs.
Methods:
We used sales data from the Moroccan subsidiary of IMS Health Intercontinental Marketing Service.
Results:
Consumption of generic antihypertensive drugs increased from 0.08 to 10.65 DDD/1 000 inhabitants/day between 1991 and 2010. In 2010, generic of the calcium channel blockers (CCBs) represented 4.08 DDD/1 000 inhabitants/day (82.09%), followed by angiotensin converting enzyme inhibitors (ACEI) by 2.40 DDD/1 000 inhabitants/day (48.29%). The generics market of CCBs is the most dominant and represented in 2010, 79.21% in volume and 62.58% in value.
Conclusion:
In developing countries like Morocco, the generic drug is a key element for access to treatment especially for the poor population.
